Anti-NQO1 antibody [A180] (ab28947)

ab28947 has been referenced in 18 publications.

1. Ghosh S et al. Global gene expression profiling of endothelium exposed to heme reveals an organ-specific induction of cytoprotective enzymes in sickle cell disease. PLoS One 6:e18399 (2011). IHC-P; Human. PubMed: 21483798
2. Ivanov AV et al. Hepatitis C Virus Proteins Activate NRF2/ARE Pathway by Distinct ROS-Dependent and Independent Mechanisms in HUH7 Cells. PLoS One 6:e24957 (2011). WB; Human. PubMed: 21931870
3. Khutornenko AA et al. From the Cover: Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci U S A 107:12828-33 (2010). WB, ICC/IF; Human. PubMed: 20566882
4. Zeller I et al. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells. Arterioscler Thromb Vasc Biol 30:1733-40 (2010). WB; Human. PubMed: 20595649
5. Yang L et al. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS One 4:e5757 (2009). WB; Human. PubMed: 19484125
6. Fischer AJ et al. Differential Gene Expression in Human Conducting Airway Surface Epithelia and Submucosal Glands. Am J Respir Cell Mol Biol : (2008). PubMed: 18703793
7. Okada K et al. Ursodeoxycholic Acid Stimulates Nrf2-Mediated Hepatocellular Transport, Detoxification and Antioxidative Stress Systems in Mice. Am J Physiol Gastrointest Liver Physiol : (2008). PubMed: 18687751
8. Cleton-Jansen AM et al. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. BMC Cancer 8:105 (2008). PubMed: 18416817
9. Dehn DL et al. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo. Mol Cancer Ther 5:1702-9 (2006). PubMed: 16891456
10. Umemura T et al. A crucial role of Nrf2 in in vivo defense against oxidative damage by an environmental pollutant, pentachlorophenol. Toxicol Sci 90:111-9 (2006). PubMed: 16352618
11. Anwar A et al. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem 278:10368-73 (2003). PubMed: 12529318
12. Zappa F et al. NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytes. J Histochem Cytochem 51:297-302 (2003). PubMed: 12588957
13. Winski SL et al. Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells. Cancer Res 62:1420-4 (2002). PubMed: 11888914
14. Siegel D et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol 59:263-8 (2001). PubMed: 11160862
15. Siegel D et al. NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells. Toxicol Lett 125:93-8 (2001). PubMed: 11701227
16. Schelonka LP et al. Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes. Invest Ophthalmol Vis Sci 41:1617-22 (2000). PubMed: 10845577
17. Moran JL et al. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci U S A 96:8150-5 (1999). PubMed: 10393963
18. Siegel D et al. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors. Clin Cancer Res 4:2065-70 (1998). PubMed: 9748120